chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 64 year old female who on 07-NOV-2007 was vaccinated with a dose of Zostavax (Oka/Merck) (658603/1081U). Concomitant therapy included lisinopril (PRINIVIL), vitamin D (unspecified) and rosuvastatin calcium (CRESTOR). On 19-NOV-2007 the patient experienced itchy spots on the right side of face. Physician did not specify if the spots were a rash. On 30-NOV-2007 the patient went to the ER because she could not breath properly. Patient was diagnosed with "uvulitis of throat." Patient was given Benadryl and steroids. Patient was not hospitalized. Patient reported to the physician that she felt congested and the physician reported that the patient had a swollen pharynx and swollen uvula. Physician also reported that the patient visited an eye doctor (date was not provided) and was diagnosed with a cornea ulcer. Patient remains on steroids. Uvulitis of the throat was considered an Other Important Medical Event. The events are improving in regards to outcome. No product quality complaint. Additional information has been requested.
pt recvd vax 14SEP92; no fever or other adverse sx until 21SEP92; fever 101 rising to 103.6 w/rash (descending) on 23SEP92; taken to ER fever 106.6 rash over entire body early PM;
There is no adverse event, this is reported due to administration error. Patient received Moderna COVID vaccine dose #1 at another facility on 4/3/21. Patient came to our facility on 5/8/21 for Moderna COVID vaccine dose #2, but received Pfizer (instead of Moderna).
Site: Pain at Injection Site-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.), Additional Details: pt's arm muscle sore for the whole month after recieving first dose. got his second dose and that arm was only sore for a few days and is now feeling normal. initially just mild soreness/ache but pt went swimming approx 3 days ago and is not having significan soreness in his arm that he got the first shot in.
This spontaneous report was received f rom a health professional refers to a patient of unknown gender and age. Information regarding patient's medical history, concurrent condition, drug reactions/allergies and concomitant therapy were unspecified. On 25-MAR-2016, the patient was vaccinated with an expired dose of ROTATEQ (lot # K013868, expiry date: 24-MAR-2016) (expired product administered). There were no known adverse events. Additional information has been requested.
I caught COVID before I was vaccinated. I mostly had a cough during the 1st 14 days. Then on the 14th day, my lungs kind of seized up, it became hard to breath, I was really tired and I became extremely hungry. I ended up having to take off a month of work due to not being able to talk/breath. I was prescribed an inhaler in Feb 2021. I'm still using the inhaler. I never had an issue with any lung conditions prior to COVID. I was also having brain fog in my forehead. It became harder to think. And then, in the spring May-June, I believe that's when the last bit of brain fog cleared up. Then in June 2021, I started to have a hard time walking due to fatigue. I also was worried about my heart due to family history. I was also in a car accident which may have attributed to the issues as well and brain injury.
Sore Arm after shot; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore Arm after shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Sore Arm after shot). At the time of the report, MYALGIA (Sore Arm after shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment details were reported.   Reporter did not allow further contact
Onset 14 hours.  Then about 5 hours of intense total body muscle pain. Then went away and was just fatigue. No recorded fever.
sharp pains ran up spine, pain in right hand, numbness in half of foot, knee problems in both knees soreness in joints. hand went total purple and went numb
One week after receiving her second covid shot she noticed a rash on her arm.  It then proceeded to spread over her whole body (arms, quads, chest, and trunk).  It causes her burning and needle-like pain on a daily basis.  The rash has persisted until the current date.  Pain and rash were so severe she went to the ER on 6/7/21.
Bad taste in mouth, cough, sneezing, headache, feeling of "hot" (no report of fever), dizziness, weakness. Has not had medical treatment.
Dizziness; Nausea; This is a spontaneous report from a contactable consumer or other non hcp. A 79-years-old male patient received bnt162b2 (BNT162B2), via an unspecified route of administration on 09Feb2021 (Batch/Lot number was not reported) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 10Feb2021 the patient experienced dizziness, nausea. The outcome of the events dizziness, nausea was unknown.  Follow-up attempts are completed. No further information is expected.
No adverse event; The physician reported that a patient received improperly stored vaccine.; This spontaneous report has been received from a physician referring to a patient of unknown age and gender. Patient's medical history, other concurrent conditions, previous drug reactions or allergies, and concomitant therapies were not provided.  On 07-OCT-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, one dose, ((strength, dose, frequency, route of administration and site of vaccination were not provided; lot number W012163 had been verified to be a valid number; expiration date was reported and established as 12-APR-2024) for prophylaxis (improper storage of product in use). Administered dose of the vaccine experienced temperature excursion of 10.1 Fahrenheit (F) for 51 hours. There was no previous temperature excursion.  No additional adverse events were reported in the patient.
symptoms of COVID; cough; nausea; headaches; Initial information was received on 29-Jul-2020 regarding an unsolicited valid non-serious case from a nurse manager.  This case involves three female patients of an unknown age who were having symptoms of COVID (Suspected COVID-19), cough, nausea and headache, while she received vaccine RABIES (HDC) VACCINE [IMOVAX RABIES].  Medical history, past medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was not reported.  On 23-Jul-2020, the patient received a first dose of suspect RABIES (HDC) VACCINE (lot R1C711M, expiry date 30-Apr-2021) via an unknown route and administration site for prophylactic vaccination.  On an unknown date in Jul-2020, patient was having symptoms of COVID (Suspected COVID-19), cough, nausea and headache (unknown latency) following the administration of RABIES (HDC) VACCINE.  It was reported that the, the patients were due for second dose tomorrow, but they were having symptoms of COVID and were going to get tested.  Details of laboratory data were not reported.  Final diagnosis was Suspected COVID-19, headaches, nausea and having a cough.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for all the events at the time of reporting.
Patient want to take the second dose of vaccine after 67 days; Sore arm; This spontaneous case was reported by a patient and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient want to take the second dose of vaccine after 67 days) and VACCINATION SITE PAIN (Sore arm) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Fecal incontinence and Social anxiety disorder.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, the patient experienced VACCINATION SITE PAIN (Sore arm). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient want to take the second dose of vaccine after 67 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient want to take the second dose of vaccine after 67 days) and VACCINATION SITE PAIN (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication and treatment information were not reported.
Non pruritic red rash on dorsum of both hands and upper chest.  No apparent distress, no breathing difficulties, vitals normal.
she started her period on 13Feb2021 at 09:00. She reported that this was unexpected since it was two weeks early and her body was mid cycle; This is a spontaneous report from a contactable consumer (patient). A 38-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution injection; Batch/Lot Number: EL9267 and expiry date was not reported), via an unspecified route of administration, administered in Arm Left on 12Feb2021 at 11:45 (at the age of 38-years-old) for COVID-19 immunisation. Medical history included acid reflux. The patient had no known allergies. The patient did not any take vaccine in four weeks. The patient did not have covid prior to vaccination. Concomitant medications included pantoprazole, cyanocobalamin (B12 INJECTION) and citalopram (IC CITALOPRAM). The patient was not tested for COVID post vaccination. The patient reported that 20 hours after she received her vaccination, she started her period on 13Feb2021 at 09:00. She reported that this was unexpected since it was two weeks early and her body was mid cycle. She was not on any form of birth control, however, her cycle was regular and predictable. The outcome of the event was reported as recovered.  No follow-up attempts are possible. No further information is expected.
24hr p/vax pt devel an inj site rxn characterized by redness, warmth, & induration;
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Feb-2022; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Feb-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Feb-2022) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2022 at 10:45 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Feb-2022 at 10:45 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Feb-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Feb-2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 27-Feb-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided by reporter. No treatment medication was provided by reporter.
Patient had a reaction to a Tdap injection, redness swelling to upper arm, lump under the skin. 25 x 20 mm. Patient told to ice area and take Ibuprofen 800 mg q 8 hrs.
06/13/05 Client RTC with complaints of pain and redness at site of Td-LDT.  Says it started 6/11/05.  redness noted 12 cm X 12 cm, warm to touch.  7.5 cm x 7 cm indurated area.  No fever.  Client to take Benadryl and ibuprofen and put cold compresses alternating with warm compresses.  To see PMD if does not resolve.  6/15/05 Client reports redness and pain subsided.
Expired product moved to fridge on date of administration; administered after the published expiration date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered after the published expiration date) and PRODUCT STORAGE ERROR (Expired product moved to fridge on date of administration) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered after the published expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired product moved to fridge on date of administration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered after the published expiration date) and PRODUCT STORAGE ERROR (Expired product moved to fridge on date of administration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The published expiration date was reported as 25-Mar-2022. The vial was moved to the fridge on the day of administration. The vial did not undergo temperature excursion.   There were no adverse events reported by the patient after the administration error.  No concomitant medications were reported.  No treatment information was reported.
5 mintues after injection I became extremely hot and felt like I was going to pass out. Nobody was around to monitor patients so I went to my car to sit in the air conditioning. 45 minutes after I noticed my throat was tight and itchy, my heart felt like it was beating out of my chest, I was itchy from head to toe, and I became dizzy.
28AUG no local reaction, no rash, fever @ 4PM; 27AUG given APAP c/o h/a 28AUG; 28AUG MD checked pt & dx allergy to mold; pt had hx of chronic allerg to mold;
Intense migraine about 17 hours after the shot Minor fever Fatigue Balls of my feet were itchy for 36-48 hours
Vaccinated with pfizer, has stuffy head and ears stuffed up. Though it was allergy. No fever.
Headache Fever - max 101.4 Pain at injection site Lethargy All were mitigated with Tylenol and lasted about 15 hours.
Client reported she was nervous and had a "thick lump" in her throat.  she reported she has a peanut allergy and now carries an Epi Pen.  Blood pressure 119/80 Pulse 90  and 02 Saturation 100%.  Client continued to state she felt a lump in her throat and was offered benadryl nasally.  Was able to tolerate left nostril dose of Benadryl intranasal 50mg  so only got 25mg.  Client reacted with yelling and cursing stating this made it worse and she felt her throat was now "burning"  She was taken to an EMS vehicle to lie down and was monitored and treated by Dr and EMS.  an IV was inserted by EMS and further medications given.  Client continued to complain of the "lump in her throat"  and that her throat was numb.  Epi pen 0.3ml given at 12.40 pm  by EMS along with Solumedrol 125mg and pepcid 20mg IV.  Client needed to bee monitored following epi pen and was feeling better before transported by EMS to hospital.
I had a mixed dose because of my reaction to Moderna. I thought it would be different with, from Pfizer; I had a mixed dose because of my reaction to Moderna. I thought it would be different with, from Pfizer; My heart went haywire; dizzy; couldn't walk; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 80B09413-168C-4041-A1A0 (Moderna).  A female patient received BNT162b2 (BNT162B2), as dose number unknown (initial pfizer dose), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Moderna (Dose: Unknown, Manufacturer: Moderna), for Covid-19 Immunization. The following information was reported: OFF LABEL USE (non-serious), INTERCHANGE OF VACCINE PRODUCTS (non-serious), outcome "unknown" and all described as "I had a mixed dose because of my reaction to Moderna. I thought it would be different with, from Pfizer"; CARDIAC DISORDER (non-serious), outcome "unknown", described as "My heart went haywire"; DIZZINESS (non-serious), outcome "unknown", described as "dizzy"; GAIT INABILITY (non-serious), outcome "unknown", described as "couldn't walk". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
LOC @ 3:55 post vaccine while standing and was guided to ground by staff. Patient denies thinners. No deformities /head trauma noted. Patient a&ox4 upon discharge. Pt was vaccinated at 3:51 hours and discharged at 4:15. Patient stable and no complaints at discharge.
On 10/29 patient had 2 episodes of crying for 4 hours each and another 4 hour episode of crying on 10/30.
Employee reported raised area of Left Deltoid, area became swollen and warm then she reported intensified itching without hive development. She took BENADRYL with mild relief, returned to report unrelieved symptoms. Employee was assessed in EOH, and sent to her PCP at clinic and seen given Rx for TAGAMET. Her PCP reported she c/o itching and throat feeling heavy.
pt recvd vax & 1 hrs post vax exp vertigo,nausea,vomiting,weakness & burning of the face;sensation of burning of the face lasted 45mins;other sx cont;pt was examined by MD who recommended forced fluids in the evening;
Telephone interview with mother. Reports that child started with a cough on 1/9/03 which stopped. On 1/12/03 had runny nose followed by congestion and wheezing next day. Was taken to hosp ER this day on 1/13/03 observed x 24 hrs then transferred to hosp. Infant remained in hospital and acutely ill. Dx: viral cond.-causing cardiomyopathy. The mecical record received on 3/23/04 states bronchiolitis. The ER record received on 3/23/04 states dyspnea.
Information has been received from a 71 year old male patient with a history of an "unspecified cardiology-related surgery recently" who on 28-MAY-2009 was vaccinated with a dose of PNEUMOVAX (dose, route and lot number not reported). Concomitant therapy included "unspecified pain medication". The patient reported that he received the vaccine from a nurse while being discharged from the hospital. The next day, on 29-MAY-2009, the patient experienced pain and swelling at the injection site. The patient stated that "he may had a dose of PNEUMOVAX three to four years ago but he was not sure". The patient reported that he had not yet contacted his physician but he was planning to do so on 29-MAY-2009. No lab tests were performed. The patient did not seek medical attention. No further information is available.
Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Severe, Systemic: Joint Pain-Severe, Systemic: Nausea-Severe, Additional Details: pt experience high fever (103 f) for the first 3 days along with nauseausness, fatigue, joint pain. Pt continued to have high fever 4th day (102 f) and nausea and severe fatigue before recovering.
12/8 I had this shot just yesterday and about 4 hours after, I got chills, headaches, body pain, and fatigue. Around the shot site is very tender and sensitive. Haven't been able to shake feeling tired. After checking in via phone in, was called back 12/9 and started taking OTC Ibuprofen.
Had Varivax 9/27/99 - has chicken pox 1/23/08.
I have had increasing tendon pain with minor activity, such as walking. This has progressed over the past six months to the point of pain at the muscle insertion site of multiple joints, including bilateral ankles, bilateral knees, bilateral hipbones, the ischial tuberosity (the most painful site), and bilateral elbows. I am also having a little of allodynia bilaterally in the arms; a soft T-shirt feels like burlap. I have begun missing work on account of the severity of the pain. My PCP has no clue what is wrong with me. He has run various tests for autoimmune issues, and the results were all normal. He has prescribed me CYMBALTA and low-dose naltrexone; so far, I haven't noticed any difference since starting the medications, but I've also heard that they take months to start working. I have pre-existing Lyme disease; I'm currently trying to get an appointment with the specialist who treated me for Lyme disease many years ago, because I hope that maybe he can decipher what is going on.
3 days post vax noted aprpox 30 small bumps around inject site; pt c/o itching unable to come in for visualization x 3 days; given DPh elixir;
* Tuesday, March 16th, I received my first Moderna shot. No immediate symptoms, felt fine. * Thursday, March 25th (9 days post-vaccination), I was sitting at my desk and experienced some kind of visual distortion (my computer monitor bounced up and down 4 times in quick succession, even though I was perfectly still). Got up from my desk and laid down, and it went away. * Tuesday, March 30th (two weeks post-vaccination), I started experiencing persistent dizziness/imbalance. It was manageable for the first couple of days, and I still went about my daily activities. * Thursday, April 1st, symptoms got noticeably worse. I had a really bad episode of vertigo/dizziness in the afternoon. This spell of bad symptoms lasted until Saturday evening/Sunday morning. I wasn?t falling down, but I would describe it as akin to being on a boat in rough seas or a plane flying through a storm. Pressure in head and ears was intense. I?ve had longstanding tinnitus, but pitch/volume definitely seemed to change somewhat. My neck was incredibly stiff, and my throat felt somewhat ?tight? (tonsils or lymph nodes in neck felt enlarged). Took ibuprofen and Benadryl on and off over next several days. * Tuesday, April 27th, symptoms are ongoing. Still having imbalance, dizziness, and non-spinning vertigo, though less severe than previously.
hands are numb; swollen tongue; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (hands are numb) and SWOLLEN TONGUE (swollen tongue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No medical history reported.  Concomitant products included LOSARTAN POTASSIUM (COZAAR), CLONIDINE, FUROSEMIDE, POTASSIUM CHLORIDE (LASIX + K), NORTRIPTYLINE, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) and ANASTROZOLE for an unknown indication.    On 09-Mar-2021 at 6:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HYPOAESTHESIA (hands are numb) and SWOLLEN TONGUE (swollen tongue). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (hands are numb) and SWOLLEN TONGUE (swollen tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.